Canada Life’s Novavax NVAX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $152K | Hold |
18,592
| – | – | ﹤0.01% | 1640 |
|
|
2025
Q4 | $125K | Buy |
18,592
+6,829
| +58% | +$51.5K | ﹤0.01% | 1693 |
|
|
2025
Q3 | $101K | Hold |
11,763
| – | – | ﹤0.01% | 1760 |
|
|
2025
Q2 | $74K | Hold |
11,763
| – | – | ﹤0.01% | 1796 |
|
|
2025
Q1 | $76K | Hold |
11,763
| – | – | ﹤0.01% | 1817 |
|
|
2024
Q4 | $94K | Hold |
11,763
| – | – | ﹤0.01% | 1823 |
|
|
2024
Q3 | $149K | Hold |
11,763
| – | – | ﹤0.01% | 1810 |
|
|
2024
Q2 | $149K | Hold |
11,763
| – | – | ﹤0.01% | 1835 |
|
|
2024
Q1 | $56K | Sell |
11,763
-61
| -0.5% | -$283 | ﹤0.01% | 2006 |
|
|
2023
Q4 | $56K | Sell |
11,824
-4,204
| -26% | -$25.7K | ﹤0.01% | 2042 |
|
|
2023
Q3 | $116K | Buy |
16,028
+7,944
| +98% | +$63.5K | ﹤0.01% | 1935 |
|
|
2023
Q2 | $61K | Buy |
8,084
+3,515
| +77% | +$27.6K | ﹤0.01% | 1984 |
|
|
2023
Q1 | $32K | Sell |
4,569
-36,008
| -89% | -$331K | ﹤0.01% | 2129 |
|
|
2022
Q4 | $419K | Buy |
40,577
+20,685
| +104% | +$365K | ﹤0.01% | 1753 |
|
|
2022
Q3 | $362K | Buy |
19,892
+7,983
| +67% | +$346K | ﹤0.01% | 1749 |
|
|
2022
Q2 | $613K | Sell |
11,909
-4,489
| -27% | -$233K | ﹤0.01% | 1624 |
|
|
2022
Q1 | $1.28M | Sell |
16,398
-540
| -3% | -$48.2K | ﹤0.01% | 1440 |
|
|
2021
Q4 | $2.42M | Buy |
16,938
+4,277
| +34% | +$735K | 0.01% | 1099 |
|
|
2021
Q3 | $2.64M | Hold |
12,661
| – | – | 0.01% | 1013 |
|
|
2021
Q2 | $2.69M | Buy |
12,661
+8,598
| +212% | +$1.58M | 0.01% | 969 |
|
|
2021
Q1 | $731K | Buy |
4,063
+114
| +3% | +$22.7K | ﹤0.01% | 1631 |
|
|
2020
Q4 | $439K | Hold |
3,949
| – | – | ﹤0.01% | 1786 |
|
|
2020
Q3 | $428K | Buy |
3,949
+495
| +14% | +$60.3K | ﹤0.01% | 1710 |
|
|
2020
Q2 | $287K | Buy |
+3,454
| New | +$132K | ﹤0.01% | 1817 |
|
|
2019
Q4 | – | Sell |
-1,567
| Closed | -$8K | – | 2770 |
|
|
2019
Q3 | $8K | Sell |
1,567
-1,387
| -47% | -$7.59K | ﹤0.01% | 1101 |
|
|
2019
Q2 | $17K | Hold |
2,954
| – | – | ﹤0.01% | 2601 |
|
|
2019
Q1 | $32K | Buy |
2,954
+1,304
| +79% | +$41.2K | ﹤0.01% | 2325 |
|
|
2018
Q4 | $58K | Hold |
1,650
| – | – | ﹤0.01% | 2321 |
|
|
2018
Q3 | $62K | Hold |
1,650
| – | – | ﹤0.01% | 2338 |
|
|
2018
Q2 | $44K | Hold |
1,650
| – | – | ﹤0.01% | 2432 |
|
|
2018
Q1 | $69K | Hold |
1,650
| – | – | ﹤0.01% | 2285 |
|
|
2017
Q4 | $41K | Hold |
1,650
| – | – | ﹤0.01% | 2410 |
|
|
2017
Q3 | $38K | Hold |
1,650
| – | – | ﹤0.01% | 2403 |
|
|
2017
Q2 | $38K | Hold |
1,650
| – | – | ﹤0.01% | 2399 |
|
|
2017
Q1 | $42K | Hold |
1,650
| – | – | ﹤0.01% | 2345 |
|
|
2016
Q4 | $42K | Hold |
1,650
| – | – | ﹤0.01% | 2366 |
|
|
2016
Q3 | $68K | Hold |
1,650
| – | – | ﹤0.01% | 2267 |
|
|
2016
Q2 | $239K | Hold |
1,650
| – | – | ﹤0.01% | 1841 |
|
|
2016
Q1 | $170K | Hold |
1,650
| – | – | ﹤0.01% | 1410 |
|
|
2015
Q4 | $277K | Hold |
1,650
| – | – | ﹤0.01% | 1110 |
|
|
2015
Q3 | $234K | Sell |
1,650
-709
| -30% | -$159K | ﹤0.01% | 1168 |
|
|
2015
Q2 | $524K | Buy |
2,359
+50
| +2% | +$8.79K | ﹤0.01% | 998 |
|
|
2015
Q1 | $370K | Buy |
2,309
+117
| +5% | +$19K | ﹤0.01% | 1054 |
|
|
2014
Q4 | $259K | Hold |
2,192
| – | – | ﹤0.01% | 1181 |
|
|
2014
Q3 | $186K | Hold |
2,192
| – | – | ﹤0.01% | 1260 |
|
|
2014
Q2 | $205K | Buy |
2,192
+1,597
| +268% | +$140K | ﹤0.01% | 1119 |
|
|
2014
Q1 | $79K | Hold |
595
| – | – | ﹤0.01% | 1526 |
|
|
2013
Q4 | $45K | Hold |
595
| – | – | ﹤0.01% | 1848 |
|
|
2013
Q3 | $38K | Buy |
+595
| New | +$33.5K | ﹤0.01% | 1050 |
|
Other funds holding NVAX
SCM
VPM
VCM
S
Canada Life's NVAX Position: Q1 2026 in Review
Canada Life held its Novavax (NVAX) position steady in Q1 2026 at 18,592 shares worth $152K. The position accounts for ﹤0.01% of the portfolio, ranked #1640.
Canada Life first reported a position in NVAX in Q3 2013 and has held it in 49 quarters since. The position peaked at $2.69M in Q2 2021. 258 funds tracked by Wall St. Rank hold NVAX as of Q1 2026.
- Canada Life held 18,592 shares of Novavax worth $152K as of Q1 2026.
- Canada Life left its Novavax share count unchanged in Q1 2026.
- Novavax made up ﹤0.01% of Canada Life's portfolio in Q1 2026, its #1640 holding.
- Canada Life first reported a position in Novavax in Q3 2013 and has held it in 49 quarters since.
- Canada Life's Novavax position peaked at $2.69M in Q2 2021.
- 258 funds tracked by Wall St. Rank held Novavax as of Q1 2026.
Based on Canada Life's 13F filing for Q1 2026, filed 14 May 2026.